Influenza News and Research

Latest Influenza News and Research

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

Scientists from the United States have recently assessed the evolutionary success of mutations accumulated across severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome. They have observed that the positively-selected mutations in the viral spike S1 subunit are primarily responsible for adaptive evolution. This indicates that the virus may undergo antigenic drift.

23 Mar 2022

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

Researchers performed a case-control study to evaluate the effectiveness of SARS-CoV-2 messenger ribonucleic acid vaccines.

23 Mar 2022

Genomic sequencing reveals unique pattern of SARS-CoV-2 Epsilon emergence in Alaska

Researchers used genomic sequencing to examine SARS-CoV-2 genomes from Alaska, United States, between December 2020 and June 2021.

23 Mar 2022

PROCOVAXED: Promoting COVID vaccination in emergency departments

Researchers examine the reasons behind COVID-19 vaccine hesitancy emergency department patients when educated through vaccine messaging platforms.

22 Mar 2022

Rubella antibodies vs. COVID-19

A new study describes a potential relationship between antibody titers against the rubella virus and the severity of COVID-19.

22 Mar 2022

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Researchers have determined the effect of booster immunization on the levels of antibodies generated, against SARS-CoV-2 variants, including the Omicron strain, in cancer patients with or without active B cell-targeted therapy.

22 Mar 2022

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Researchers performed an in situ analysis to evaluate the correlation between CD48 expression and COVID-19.

22 Mar 2022

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

The immune system deteriorates with age, making COVID-19 particularly deadly in older people - but to date, no clinically available medication addresses this key risk factor.

21 Mar 2022

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country's objectives in its fight against the coronavirus.

21 Mar 2022

Study links the usage of oral polio vaccines with lower incidence of COVID-19

A study published in the journal PLOS ONE showed how countries using oral polio vaccine have a lower incidence of coronavirus disease (COVID-19) when compared to those using inactivated polio vaccine – suggesting that the oral vaccine may either prevent the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the individual level or slow down the transmission in the community.

21 Mar 2022

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Researchers provide insight on the potentially significant impact of aerosol pH on the transmission of SARS-CoV-2.

20 Mar 2022

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Researchers assessed the role of hypoxia-inducible factors in SARS-CoV-2 infection, respiratory symptoms, and epithelial damage.

18 Mar 2022

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Researchers conducted a retrospective analysis to evaluate the duration of the SARS-CoV-2 Omicron variant virus shedding

18 Mar 2022

Influenza News and Research

Latest Influenza News and Research

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

Genomic sequencing reveals unique pattern of SARS-CoV-2 Epsilon emergence in Alaska

PROCOVAXED: Promoting COVID vaccination in emergency departments

Rubella antibodies vs. COVID-19

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

Study links the usage of oral polio vaccines with lower incidence of COVID-19

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

Research demonstrates within-host seasonal immunity

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in